|
391. (Journal Article): Anti-diabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S ABSTRACT:
BACKGROUND. Glucagon-like peptide-1 (7-36) amide (glucagon-like insulinotropic peptide, or GLIP) is a gastrointestinal peptide that potentiates the release of insulin in physiologi...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T2DM
»
Insulinotropic Subst...
»
Incretins
»
GLP-1
»
Journal Article
submitted: Nov 16, 2005 |
|
392. (Journal Article): Insulin gene transfer enhances the function of human islet grafts.
Deng S, Vatamaniuk M, Lian MM, Doliba N, Wang J, Bell E, Wolf B, Raper S, Matschinsky FM, Markmann JF ABSTRACT:
AIMS/HYPOTHESIS: Recent success in islet transplantation renews the hope for the complete cure of patients afflicted with Type 1 diabetes. However, in the Edmonton series, two to f...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Transplantation
»
Islet Cells
»
Follow-up
»
Islet Cell Graft Fun...
»
Preserving and Enhan...
»
Journal Article
submitted: Jan 15, 2006 |
|
393. (Journal Article): C-peptide prevents hippocampal apoptosis in type 1 diabetes.
Li Z-G, Zhang W, Sima AAF ABSTRACT:
To explore mechanisms underlying central nervous system (CNS) complications in diabetes, we examined hippocampal neuronal apoptosis and loss, and the effect of C-peptide replacemen...
|
»
Diabetes OD
»
Diabetic Complicatio...
»
Neural
»
Journal Article
submitted: Mar 09, 2006 |
|
394. (Journal Article): Development of Late-Stage Diabetic Nephropathy in OVE26 Diabetic Mice.
Zheng S, Noonan WT, Metreveli NS, Coventry S, Kralik PM, Carlson EC, Epstein PN ABSTRACT:
OVE26 mice are a transgenic model of severe early-onset type 1 diabetes. These mice develop diabetes within the first weeks of life and can survive well over a year with no insulin...
|
»
Diabetes OD
»
Diabetic Complicatio...
»
Renal
»
Nephropathy
»
Causes for Onset
»
Chronic Hyperglycemi...
»
Journal Article
submitted: May 26, 2005 |
|
395. (Journal Article): Bone and mineral metabolism in BB rats with long-term diabetes.
Verhaeghe J, Van Herck E, Visser WJ, Suiker AM, Thomasset M, Einhorn TA, Faierman E, Bouillon R ABSTRACT:
The effect of long-term diabetes mellitus on bone and mineral metabolism was studied in BB rats. Diabetic rats were treated with 1 U of long-acting insulin every other day for 12 w...
|
»
Diabetes OD
»
Diabetic Complicatio...
»
Renal
»
Mineral Metabolism
»
Calbindin expression
»
Journal Article
submitted: May 26, 2005 |
|
396. (Journal Article): Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro.
Podesta F, Romeo G, Liu WH, Krajewski S, Reed JC, Gerhardinger C, Lorenzi M ABSTRACT:
Diabetes of even short duration accelerates the death of capillary cells and neurons in the inner retina by a process consistent with apoptosis. We examined whether the process is ...
|
»
Diabetes OD
»
Diabetic Complicatio...
»
Ophthalmic
»
Retinal Cell Death
»
Apoptotic Regulators...
»
Bax
»
Journal Article
submitted: Jun 14, 2005 |
|
397. (Journal Article): Incretin mimetics as emerging treatments for type 2 diabetes.
Joy SV, Rodgers PT, Scates AC ABSTRACT:
OBJECTIVE: To review the physiology, pharmacology, and clinical efficacy of glucagon-like peptide (GLP-1) and the incretin mimetics exenatide and liraglutide in clinical studies. D...
|
»
Diabetes OD
»
Disease Management
»
T2DM
»
Metabolic Control
»
Anti-Hyperglycemic a...
»
Incretin Hormones
»
GLP-1
»
Effectivity of GLP-1...
»
Journal Article
submitted: Nov 29, 2005 |
|
398. (Journal Article): Improved glycemic control with no weight in-crease in patients with type 2 diabetes after once-daily treat-ment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial.
Madsbad S, Schmitz O, Ranstam J, Jakobsen G, Matthews DR ABSTRACT:
OBJECTIVE: Liraglutide is a long-acting glucagon-like peptide 1 analog designed for once daily injection. This study assessed the efficacy and safety of liraglutide after 12 weeks ...
|
»
Diabetes OD
»
Disease Management
»
T2DM
»
Metabolic Control
»
Anti-Hyperglycemic a...
»
Incretin Hormones
»
GLP-1
»
Effectivity of GLP-1...
»
Effectivity of Admin...
»
Long-Acting GLP-1 An...
»
Journal Article
submitted: Nov 19, 2005 |
|
399. (Journal Article): Decreased first-phase secretion of insulin may play a role in the development of insulin resistance.
Wittmann I, Soltesz G, Jermendy G, Nagy J ABSTRACT:
Decreased first-phase secretion of insulin may play a role in the development of insulin resistance. In the development of type 2 diabetes an abnormal function of the beta-cells an...
|
»
Diabetes OD
»
Disease Management
»
T2DM
»
Metabolic Control
»
Insulin Therapies
»
Insulin Resistance
»
Journal Article
submitted: Jun 17, 2005 |
|
400. (Journal Article): Genital infections among girls with type 1 diabetes
[No indication of authors] ABSTRACT:
The aim of the study was to investigate the relation between genital infections (frequency, etiology, clinical presentation) among girls with type 1 diabetes and some factors as ag...
|
»
Diabetes OD
»
Disease Management
»
Metabolic Control
»
Journal Article
submitted: Aug 22, 2004 |
|